Inflammatory cardiomyopathy (myocarditis): Which patients should be treated with anti-inflammatory therapy?

Circulation

Volumn 104, Issue 1, 2001, Pages 4-6

  Parrillo, Joseph E ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiomyopathy; Editorials; Heart failure; Immunohistochemistry; Inflammation; Myocarditis

Indexed keywords

ANTIINFLAMMATORY AGENT; AZATHIOPRINE; PREDNISONE;

DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; MYOCARDITIS; PATIENT SELECTION; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0035800071     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc2601.092124     Document Type: Editorial

References (14)

1. The cardiomyopathies and myocarditides
2. Idiopathic dilated cardiomyopathy
3. Myocarditis
4. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death. Learning from the past for the future
5. Myocarditis: How should we treat in 1998?
6. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis
7. Myocarditis
8. A clinical trial of immunosuppressive therapy for myocarditis
9. Evaluation of postmortem endomyocardial biopsy specimens from 28 patients with lymphocytic myocarditis: Implications for role of sampling error
10. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy
11. Intervention in myocarditis and acute cardiomyopathy with immune globulin: Results from the randomized placebo controlled IMAC trial
12. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: Two-year follow-up results
13. Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: A nonhistologic marker of myocarditis
14. Invited anniversary review: HLA associated diseases